Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Nucleocytoplasmic transport defects in neurodegeneration - Cause or consequence?

Hutten S, Dormann D.

Semin Cell Dev Biol. 2019 Jun 5. pii: S1084-9521(18)30190-3. doi: 10.1016/j.semcdb.2019.05.020. [Epub ahead of print] Review.

PMID:
31152789
2.

Perturbations in Traffic: Aberrant Nucleocytoplasmic Transport at the Heart of Neurodegeneration.

Fahrenkrog B, Harel A.

Cells. 2018 Nov 26;7(12). pii: E232. doi: 10.3390/cells7120232.

3.

Impaired protein degradation in FTLD and related disorders.

Götzl JK, Lang CM, Haass C, Capell A.

Ageing Res Rev. 2016 Dec;32:122-139. doi: 10.1016/j.arr.2016.04.008. Epub 2016 May 7. Review.

PMID:
27166223
4.

Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.

Kim HJ, Taylor JP.

Neuron. 2017 Oct 11;96(2):285-297. doi: 10.1016/j.neuron.2017.07.029. Review.

5.

Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.

Zhang K, Grima JC, Rothstein JD, Lloyd TE.

Nucleus. 2016 Apr 25;7(2):132-7. doi: 10.1080/19491034.2016.1172152. Epub 2016 Apr 26. Review.

6.

The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Ferreira PA.

Cell Mol Life Sci. 2019 Jun;76(12):2247-2273. doi: 10.1007/s00018-019-03029-0. Epub 2019 Feb 11. Review. Erratum in: Cell Mol Life Sci. 2019 Mar 28;:.

PMID:
30742233
7.

RNA Nucleocytoplasmic Transport Defects in Neurodegenerative Diseases.

Boehringer A, Bowser R.

Adv Neurobiol. 2018;20:85-101. doi: 10.1007/978-3-319-89689-2_4. Review.

PMID:
29916017
8.

Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.

Jovičić A, Paul JW 3rd, Gitler AD.

J Neurochem. 2016 Aug;138 Suppl 1:134-44. doi: 10.1111/jnc.13642. Epub 2016 Jun 15. Review.

9.

TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD.

Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin-Asp PG, Chen YH, Duong DM, Seyfried NT, Powers MA, Kukar T, Hales CM, Gearing M, Cairns NJ, Boylan KB, Dickson DW, Rademakers R, Zhang YJ, Petrucelli L, Sattler R, Zarnescu DC, Glass JD, Rossoll W.

Nat Neurosci. 2018 Feb;21(2):228-239. doi: 10.1038/s41593-017-0047-3. Epub 2018 Jan 8.

10.

FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins.

Steyaert J, Scheveneels W, Vanneste J, Van Damme P, Robberecht W, Callaerts P, Bogaert E, Van Den Bosch L.

Hum Mol Genet. 2018 Dec 1;27(23):4103-4116. doi: 10.1093/hmg/ddy303.

11.

TDP-43 and FUS en route from the nucleus to the cytoplasm.

Ederle H, Dormann D.

FEBS Lett. 2017 Jun;591(11):1489-1507. doi: 10.1002/1873-3468.12646. Epub 2017 Apr 23. Review.

12.

Inside out: the role of nucleocytoplasmic transport in ALS and FTLD.

Boeynaems S, Bogaert E, Van Damme P, Van Den Bosch L.

Acta Neuropathol. 2016 Aug;132(2):159-73. doi: 10.1007/s00401-016-1586-5. Epub 2016 Jun 6. Review.

13.

The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.

Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, Daley EL, Miller SJ, Cunningham KM, Vidensky S, Gupta S, Thomas MA, Hong I, Chiu SL, Huganir RL, Ostrow LW, Matunis MJ, Wang J, Sattler R, Lloyd TE, Rothstein JD.

Nature. 2015 Sep 3;525(7567):56-61. doi: 10.1038/nature14973. Epub 2015 Aug 26.

14.

Microtubules Deform the Nuclear Membrane and Disrupt Nucleocytoplasmic Transport in Tau-Mediated Frontotemporal Dementia.

Paonessa F, Evans LD, Solanki R, Larrieu D, Wray S, Hardy J, Jackson SP, Livesey FJ.

Cell Rep. 2019 Jan 15;26(3):582-593.e5. doi: 10.1016/j.celrep.2018.12.085.

15.

Assay to Measure Nucleocytoplasmic Transport in Real Time within Motor Neuron-like NSC-34 Cells.

Shani T, Levy M, Israelson A.

J Vis Exp. 2017 May 16;(123). doi: 10.3791/55676.

16.

Pathomechanisms of TDP-43 in neurodegeneration.

Gao J, Wang L, Huntley ML, Perry G, Wang X.

J Neurochem. 2018 Feb 27. doi: 10.1111/jnc.14327. [Epub ahead of print] Review.

17.

Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?

Deng Z, Sheehan P, Chen S, Yue Z.

Mol Neurodegener. 2017 Dec 28;12(1):90. doi: 10.1186/s13024-017-0232-6. Review.

18.

Huntington's Disease: Nuclear Gatekeepers Under Attack.

Veldman MB, Yang XW.

Neuron. 2017 Apr 5;94(1):1-4. doi: 10.1016/j.neuron.2017.03.032.

19.

Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Weishaupt JH, Hyman T, Dikic I.

Trends Mol Med. 2016 Sep;22(9):769-783. doi: 10.1016/j.molmed.2016.07.005. Epub 2016 Aug 4. Review.

PMID:
27498188
20.

Engineering enhanced protein disaggregases for neurodegenerative disease.

Jackrel ME, Shorter J.

Prion. 2015;9(2):90-109. doi: 10.1080/19336896.2015.1020277. Review.

Supplemental Content

Support Center